Skip to main content
Contact Us
Subscribe
e-Edition
Sign up for free daily newsletters
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Home
Contact Us
Terms of Use
Privacy Policy
Subscription Services
Submission Forms
Promote Your Event
e-Edition
Place an Ad
Local Weather
News
Local News
Elections
Sports
Business
Events
Obits
Legals
Photos
Videos
e-Edition
Recent e-Editions
Archived e-Editions (Press Reader)
Classifieds
Place an ad
Submit News
Letter to the Editor
Anniversaries
Engagement
Birth Announcement
Wedding
News Tips
Other KPC Newspapers
Herald Republican (Steuben County)
News Sun (Noble and LaGrange counties)
The Star (DeKalb County)
Advance Leader (western Noble County)
Albion New Era (central Noble County)
Butler Bulletin (Butler, DeKalb County)
Garrett Clipper (Garrett, DeKalb County)
Churubusco News (Churubusco and Whitley County)
Greater Fort Wayne Business Weekly
IN|Aboite News
IN|All Sports
IN|Fort Wayne
IN|New Haven News
IN|Northwest News (Huntertown, northwest Allen County)
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glycomimetics Inc
(NQ:
GLYC
)
3.050
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
3.050
Bid (Size)
3.040 (3)
Ask (Size)
3.160 (2)
Prev. Close
3.050
Today's Range
3.050 - 3.050
52wk Range
0.5100 - 3.600
Shares Outstanding
52,423,944
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 06, 2023
From
GlycoMimetics, Inc.
Via
Business Wire
Top 5 Health Care Stocks That May Dip
January 27, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Performance
YTD
+4.81%
+4.81%
1 Month
+9.71%
+9.71%
3 Month
+347.81%
+347.81%
6 Month
+246.59%
+246.59%
1 Year
+185.05%
+185.05%
More News
Read More
GlycoMimetics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
December 28, 2022
Via
Benzinga
US Stocks Rise; Dow Gains 100 Points
December 28, 2022
Via
Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
December 15, 2022
Via
Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
December 28, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 15, 2022
Via
InvestorPlace
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
December 15, 2022
Via
Benzinga
GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia presented at ASH Annual Meeting
December 12, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
December 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 21, 2022
Via
Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 11, 2022
Via
Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
November 11, 2022
Via
Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Via
Benzinga
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2022
November 09, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics to Participate in Two Upcoming Investor Conferences
November 08, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Will Be Presented at ASH Annual Meeting
November 03, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics to Report Third Quarter Financial Results on November 9, 2022
November 02, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 20, 2022
Via
Benzinga
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 09, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022
From
GlycoMimetics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.